STOCK TITAN

LifeVantage (NASDAQ: LFVN) CEO to retire as company furnishes Q2 results

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

LifeVantage Corporation filed a current report describing two key updates. The company issued a press release announcing financial results for the three and six months ended December 31, 2025, which is furnished as Exhibit 99.1. The report also discloses that President and Chief Executive Officer Steven R. Fife has decided to retire and will resign as CEO and from the board, with his resignation expected to be effective in April 2026. The company states that Mr. Fife’s decision to retire is not due to any disagreement regarding operations, financial policies, or practices, and additional details are provided in a second press release furnished as Exhibit 99.2.

Positive

  • None.

Negative

  • None.

Insights

LifeVantage announces CEO retirement and furnishes recent results.

LifeVantage Corporation reports that President and CEO Steven R. Fife plans to retire and will step down from both the CEO role and the board, with his resignation expected to be effective in April 2026. The company explicitly notes his decision is not due to any disagreement over operations or financial policies.

The filing also furnishes a press release with financial results for the three and six months ended December 31, 2025, but does not detail figures in this excerpt. Investors often treat leadership transitions and recent operating results together when assessing continuity and strategic direction, especially when a sitting CEO is both the chief executive and a director.

Further information on quarterly performance is contained in Exhibit 99.1, while Exhibit 99.2 addresses Mr. Fife’s retirement. Subsequent disclosures may clarify succession plans and any changes to the board or executive structure around the expected effective date in April 2026.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
0000849146false00008491462026-01-302026-01-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ______________________________
 FORM 8-K
 ______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 30, 2026
 ______________________________
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
______________________________
Delaware001-3564790-0224471
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)(IRS Employer
Identification No.)
3300 Triumph Blvd, Suite 700
Lehi, Utah 84043
(Address of principal executive offices, including zip code)
(801) 432-9000
(Registrant's telephone number)
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, par value $0.0001LFVNThe Nasdaq Stock Market LLC
Title of each classTrading Symbol(s)Name of each exchange on which registered
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company 
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 



Item 2.02.    Results of Operations and Financial Condition.
On February 4, 2026, LifeVantage Corporation (the “Company”) issued a press release announcing its financial results for the three and six months ended December 31, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference.
The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 30, 2026, Steven R. Fife notified the Company's board of directors (the “Board”) of his decision to retire as President and Chief Executive Officer and from the Board, with such resignation expected to be effective in April 2026. Mr. Fife’s decision to retire is not the result of any disagreement with the Company on any matter relating to the Company's operations, financial policies or practices.
More information on Mr. Fife’s retirement can be found in the press release furnished as Exhibit 99.2 to this current report on Form 8-K and incorporated herein by reference.
Item 9.01.    Financial Statements and Exhibits.
(d)    Exhibits
Exhibit No.
Description

99.1
Press Release issued by the Company on February 4, 2026, announcing its financial results for the three and six months ended December 31, 2025.
99.2
Press Release issued by the Company on February 4, 2026, announcing Mr. Fife's retirement.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date:February 4, 2026By:LIFEVANTAGE CORPORATION

/s/ Carl A. Aure
Name:Carl A. Aure
Title:Chief Financial Officer

FAQ

What did LifeVantage (LFVN) disclose in this 8-K filing?

LifeVantage disclosed two main items: a furnished press release with financial results for the three and six months ended December 31, 2025, and the planned retirement of President and CEO Steven R. Fife, who will also resign from the board in April 2026.

Which financial period does LifeVantage’s latest results cover in this 8-K?

The 8-K states that LifeVantage issued a press release with financial results for the three and six months ended December 31, 2025. That release is furnished as Exhibit 99.1 and provides details on the company’s operating performance over that half-year period.

What leadership change did LifeVantage (LFVN) announce in this filing?

LifeVantage announced that Steven R. Fife has decided to retire as President and Chief Executive Officer and resign from the board. His resignation is expected to be effective in April 2026, marking a planned leadership transition at both the management and board levels.

Did LifeVantage indicate any disagreement behind the CEO’s retirement?

The filing states that Steven R. Fife’s decision to retire is not the result of any disagreement with LifeVantage regarding its operations, financial policies, or practices. This language is intended to clarify that his departure is not tied to a disclosed dispute or policy conflict.

Where can investors find more details on LifeVantage’s quarterly results?

Additional details are in the press release furnished as Exhibit 99.1 to the 8-K. That press release, dated February 4, 2026, discusses LifeVantage’s financial results for the three and six months ended December 31, 2025, and is incorporated by reference in the report.

How did LifeVantage communicate Steven R. Fife’s retirement to the market?

LifeVantage communicated Steven R. Fife’s retirement through the 8-K and a dedicated press release furnished as Exhibit 99.2. The exhibit, dated February 4, 2026, provides more information about his planned retirement and upcoming resignation as President, CEO, and board member.
Lifevantage Corp

NASDAQ:LFVN

View LFVN Stock Overview

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

56.29M
10.55M
Packaged Foods
Pharmaceutical Preparations
Link
United States
LEHI